Up to 70 percent of all visits to the doctor are due to dietary factors.

70 percent of major life-threatening diseases such as respiratory problems, heart disease, stroke (a condition in which blood flow to part of the brain is blocked), cancer, and diabetes are directly related to our diet and lifestyle.

50 percent of these diseases can be prevented with good nutrition and lifestyle changes.

Nutrition is eating the right amount of nutrients our body needs every day in the right amounts.

Our Nutrition program / Wellness Centre aims at preventing malnutrition related illnesses.

Hospital-acquired infections (HAIs) also known as "Nosocomial" or " Health care-associated infections", are infections that patients contract during or shortly after receiving health care services.

Furthermore, they include occupational infections among staff. HAIs represent the most frequent adverse event during healthcare delivery.

Hospital-acquired infections HAIs are a serious threat to healthcare safety.

Preventing HAIs is a top priority for WHO, CDC and its partners in public health and healthcare.

The CDC reports that 4% of patients have HAI.

ICMR study results of year-long surveillance of Hospital acquired infections (HAIs) in 120 ICUs in 39 centres across India reveals 38% of superbug - infected ICU patients die in 14 days.

It is very heartening to know that the patients admitted in ICUs for the treatment of various other ailments without any prior infections are dying in 14 days from the infections acquired during their stay in the hospitals.

Every day, HAI results in prolonged hospital stays, long-term disability, increased resistance of microorganisms to antimicrobials, massive additional costs for health systems, high costs for patients and their family, and unnecessary deaths.

Based on data from several countries, it can be estimated that each year, hundreds of millions of patients around the world are affected by HAI.

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines.

As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death.

Antimicrobial resistance (AMR) is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.

AMR affects countries in all regions and at all income levels. Its drivers and consequences are exacerbated by poverty and inequality, and low- and middle-income countries are most affected.

Health experts - WHO, AMR Industry Alliance, CARB-X and others demand 10% reduction in bacterial AMR fatalities by 2030.

But the fact is that nobody knows how to reduce the death rate in ICUs. It is because there is no availability of safe and effective infection prevention method suitable for use in ICUs fully occupied with patients.

The clinical pipeline of new antimicrobials to tackle AMR is dry. Hence, there is an urgent need to develop new antimicrobials / to find a new application for the already available antimicrobials to tackle Antimicrobial Resistance.

Awareness and robust preventive measures are essential in hospital settings, to reduce HAI / AMR death rates.